iBio, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
iBio, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • iBio, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 8.64M shares, a 68.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.64M -19M -68.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 8.62M +7.61M +749% Jun 30, 2024 10-Q 2024-11-12
Q1 2024 8.52M -3.85M -31.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 3.24M -9.12M -73.8% Dec 31, 2023 10-Q 2024-02-09
Q3 2023 27.7M +18.6M +207% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.02M -7.71M -88.4% Jun 30, 2023 10-K/A 2024-09-24
Q1 2023 12.4M -206M -94.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 12.4M -206M -94.3% Dec 31, 2022 10-Q/A 2023-05-19
Q3 2022 9.01M -209M -95.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 8.73M +12.2K +0.14% Jun 30, 2022 10-K 2023-09-27
Q1 2022 218M +2.03M +0.94% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 218M +6.29M +2.97% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 218M +37.6M +20.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 8.71M -131M -93.8% Jun 30, 2021 10-K 2022-10-11
Q1 2021 216M +109M +101% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 212M +157M +288% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 180M +156M +647% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 140M +120M +595% Jun 30, 2020 10-K 2021-09-28
Q1 2020 107M +91.3M +569% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 54.6M +35.7M +190% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 24.2M +5.82M +31.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 20.2M +4.11M +25.6% Jun 30, 2019 10-K 2020-10-13
Q1 2019 16M -99.9M -86.2% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 18.8M -96.5M -83.7% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 18.3M -74.5M -80.2% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 16M +7.13M +80% Jun 30, 2018 10-K 2019-08-26
Q1 2018 116M +26.8M +30.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 115M +26.2M +29.4% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 92.8M +3.71M +4.16% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 8.91M -80.2M -90% Jun 30, 2017 10-K 2018-09-18
Q1 2017 89.1M +6.51M +7.88% Mar 31, 2017 10-K 2017-09-15
Q4 2016 89.1M +11.8M +15.2% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 89.1M +11.8M +15.2% Sep 30, 2016 10-Q 2016-11-18
Q2 2016 89.1M +11.9M +15.4% Jun 30, 2016 10-K 2017-09-15
Q1 2016 82.6M +8.54M +11.5% Mar 31, 2016 10-Q 2016-05-23
Q4 2015 77.3M +5.34M +7.42% Dec 31, 2015 10-Q 2016-02-22
Q3 2015 77.3M +9.87M +14.6% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 77.2M +11.6M +17.6% Jun 30, 2015 10-K 2016-10-13
Q1 2015 74.1M +8.43M +12.8% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 72M +7.54M +11.7% Dec 31, 2014 10-Q/A 2015-02-24
Q3 2014 67.5M +10.8M +19% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 65.6M +8.95M +15.8% Jun 30, 2014 10-K 2015-10-13
Q1 2014 65.6M +17.9M +37.4% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 64.4M +16.7M +34.9% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 56.7M +8.93M +18.7% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 56.7M +8.93M +18.7% Jun 30, 2013 10-K 2014-09-29
Q1 2013 47.8M 0 0% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 47.8M +15.4M +47.5% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 47.8M +15.4M +47.5% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 47.8M +15.4M +47.5% Jun 30, 2012 10-K/A 2013-10-04
Q1 2012 47.8M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 32.4M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 32.4M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 32.4M Jun 30, 2011 10-K/A 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.